Morgan Stanley’s Mural Oncology MURA Stock Holding History

Morgan Stanley’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-102,173	Closed	-$211K	–	8382
2025 Q3	$211K	Buy	102,173 +81,551	+395%	+$175K	﹤0.01%	5863
2025 Q2	$50.9K	Sell	20,622 -14,442	-41%	-$34K	﹤0.01%	6353
2025 Q1	$44.2K	Sell	35,064 -51,431	-59%	-$188K	﹤0.01%	6313
2024 Q4	$279K	Buy	86,495 +51,059	+144%	+$180K	﹤0.01%	5662
2024 Q3	$111K	Sell	35,436 -19,322	-35%	-$62.9K	﹤0.01%	5964
2024 Q2	$172K	Sell	54,758 -23,995	-30%	-$88.4K	﹤0.01%	5746
2024 Q1	$385K	Sell	78,753 -142,613	-64%	-$692K	﹤0.01%	5429
2023 Q4	$1.31M	Buy	+221,366	New	+$890K	﹤0.01%	5175

Morgan Stanley's MURA Position: Q4 2025 in Review

Morgan Stanley sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 102,173 shares — an estimated $211K sold.

Morgan Stanley first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $1.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Morgan Stanley reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Morgan Stanley sold 102,173 Mural Oncology shares in Q4 2025, an estimated $211K.
Morgan Stanley first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Morgan Stanley's Mural Oncology position peaked at $1.31M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.